Recognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey studyopen accessRecognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey study
- Other Titles
- Recognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey study
- Authors
- Gweon, Tae-Geun; Lee, Yoo Jin; Yim, Sung Kyun; Kim, Seung Yong; Choi, Chang Hwan; Cho, Young-Seok; Microbiome Research Group of the Korean Society for Neurogastroenterology and Motility
- Issue Date
- Nov-2022
- Publisher
- 대한내과학회
- Keywords
- Fecal microbiota transplantation; Clostridioides difficile infection; Surveys and questionnaires
- Citation
- The Korean Journal of Internal Medicine, v.38, no.1, pp 48 - 55
- Pages
- 8
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- The Korean Journal of Internal Medicine
- Volume
- 38
- Number
- 1
- Start Page
- 48
- End Page
- 55
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/61905
- DOI
- 10.3904/kjim.2022.206
- ISSN
- 1226-3303
2005-6648
- Abstract
- Background/Aims
Fecal microbiota transplantation (FMT) represents a treatment option for recurrent Clostridioides difficile infection (CDI). Recently, FMT has been investigated in various clinical settings other than CDI. This study examined Korean physicians’ recognition of FMT and their attitudes toward this procedure.
Methods
An online questionnaire included questions on indications for FMT, the FMT process, physicians’ attitudes toward FMT for the treatment of CDI and non-CDI diseases, and possible concerns.
Results
Finally, 107 physicians responded to this survey: 66 (61.7%) had experience of performing FMT, and 86 (80.4%) replied that they were willing to perform FMT for CDI. Two-thirds of physicians (63.6%, n = 68) would perform FMT for recurrent CDI on patients who had at least three recurrences. The most common obstacle to performing FMT for the treatment of CDI was the lack of regulations or guidelines (55.1%, n = 59). Seventy-seven (72.0%) physicians would consider FMT for non-CDI diseases when conventional treatment had failed. The most common obstacle for FMT for the treatment of non-CDI diseases was low treatment efficacy (57.0%, n = 61).
Conclusions
Two-thirds of Korean physicians had experience of performing FMT, and many performed FMT for recurrent CDI. The results of this study will prove useful to researchers and practitioners in FMT in Korea.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.